1. Home
  2. IMNN

IMNN

Imunon Inc.

Logo Imunon Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

Founded: 1982 Country:
United States
United States
Employees: N/A City: LAWRENCEVILLE
Market Cap: 14.0M IPO Year: 1985
Target Price: $13.00 AVG Volume (30 days): 225.0K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.16 EPS Growth: N/A
52 Week Low/High: $0.48 - $2.00 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: